Stomatitis Clinical Trial
Official title:
Clinical Evaluation of an Experimental Solution Based on Ricinus Communis Compared to Sodium Hypochlorite for Denture Cleansing
This clinical trial evaluated Ricinus communis and sodium hypochlorite solutions in different concentrations for denture cleanliness, regarding biofilm removal capacity, remission of atrophic chronic candidiasis, degree of patient satisfaction and antimicrobial action against specific microorganism. Sixty-four denture wearers with absence (n=40) or presence of Candidiasis (n=24) were selected and oriented to brush their dentures with a specific brush and neutral soap for 3 minutes, 3 times a day and immerse them, once a day, in hygiene solutions (0.25% sodium hypochlorite - S1 and 0.5% - S2, 10% R. communis - S3; Saline - S4: control) during 20 minutes, for 7 days. The solutions were used in a randomized, double blind and cross form with washout periods. To quantify biofilm with software ImageTool 3.0, the inner surface was disclosed (1% neutral red) and photographed at the end of each period. The Candidiasis remission was assessed by scores before and after the use of solutions. Patient satisfaction was assessed by questionnaire. Antimicrobial activity was determined by Colony Forming Units (CFU) counts of Streptococcus mutans, Candida spp., and gram-negative microorganisms. For collecting biofilm, internal surface of each maxillary complete denture was brushed with saline solution, and the biofilm suspension obtained. After serial dilutions (100 - 10-3), 50 uL aliquots were seeded in Petri dishes containing Mitis salivarius agar base, CHROMagar Candida® and MacConkey agar for detecting S. mutans, Candida spp., or gram-negative microorganisms, respectively. After incubation, colonies were counted, and values in CFU/mL were calculated. Biofilm removal was analyzed as a split-plot with two variation factors: inflammation and solutions. The candidiasis remission was analyzed after adjustment using multinomial logistic regression. Logistic regression analysis and compound symmetry was adopted for patient satisfaction. The antimicrobial action was analyzed with Friedman´s test. Antimicrobial action data were processed after transformation - log10 (CFU + 1) - and were analyzed by Friedman test (α = 0.05).
Sixty-four denture wearers with (n=24) and without Candidiasis (n=40) were enrolled and instructed to brush and immerse their dentures in 4 different storage solutions (S1: 0.25% sodium hypochlorite; S2: 0.5% sodium hypochlorite; S3: 10% R. communis; and S4: Saline/Control). The interventions were randomly performed in a double blind and crossover format with washout periods. After 7 days of brushing and storage, the biofilm formed in the inner surfaces of dentures was disclosed and photographed to quantification. Candidiasis remission was assessed by scores and the patient satisfaction by a questionnaire. Antimicrobial activity of the solutions was determined by counting the Colony Forming Units (CFUs) of Streptococcus mutans, Candida spp., and gram-negative microorganisms. For collecting biofilm, each complete upper denture was placed in a Petri dish, its internal surface was brushed (Tek brush) with saline solution for 2 min, and the biofilm suspension was transferred to a test tube. After serial dilutions (100 - 10-3), 50 uL aliquots were seeded in Petri dishes containing Mitis salivarius agar base, CHROMagar Candida® and MacConkey agar for detecting S. mutans, Candida spp., or gram-negative microorganisms, respectively. After incubation, colonies were counted, and values in CFU/mL were calculated. ;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02229136 -
Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus
|
Phase 2 | |
Completed |
NCT02762019 -
Laser for Oral Mucositis in Pediatric Onco-hematology
|
Phase 3 | |
Recruiting |
NCT02945878 -
Predictive Factors of Acute Oral Mucositis Induced by Chemo-radiotherapy for Local Advanced Nasopharyngeal Carcinoma
|
N/A | |
Recruiting |
NCT05878405 -
Methylene Blue Mouthwash for the Treatment of Oral Mucositis Pain in Patients With Cancer
|
Phase 3 | |
Completed |
NCT00323518 -
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
|
Phase 2 | |
Terminated |
NCT02326675 -
Cryotherapy in the Prevention of Chemotherapy-Induced Mucositis in Stem Cell Transplant
|
N/A | |
Active, not recruiting |
NCT01099891 -
The Clinical Study for Evaluation of Efficacy and Safety of EGF on Oral Mucositis in Radiation Therapy Patients
|
Phase 3 | |
Terminated |
NCT01092975 -
Safety of Phenylephrine for Oral Mucositis Prevention
|
Phase 1 | |
Terminated |
NCT00031551 -
Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury
|
Phase 2 | |
Completed |
NCT00385515 -
Efficacy of SNX-1012 in the Treatment of Oral Mucositis
|
Phase 2 | |
Completed |
NCT03200340 -
EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation
|
Phase 2 | |
Not yet recruiting |
NCT05323058 -
The Use of Tulsi Extract for The Management of Oral Mucositis in Head & Neck Cancer Patients Undergoing Radiotherapy
|
Phase 2 | |
Completed |
NCT01837446 -
Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer
|
Phase 2/Phase 3 | |
Completed |
NCT00104065 -
Safety and Efficacy of CG53135-05 in the Prevention of Oral Mucositis in Patients Receiving Bone Marrow Transplant
|
Phase 2 | |
Completed |
NCT03469284 -
MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN)
|
Phase 2 | |
Not yet recruiting |
NCT03778008 -
Recombinant Bovine Basic Fibroblast Growth Factor for the Treatment of Radiation Induced Oral Mucositis
|
Phase 2 | |
Terminated |
NCT00075023 -
Effectiveness of Topical Thalidomide to Treat Chronic Graft-Versus-Host-Disease Related Stomatitis
|
Phase 2 | |
Not yet recruiting |
NCT05010928 -
Using Tea-based Mouthwash Relieve Stomatitis and Oral Ulcers
|
Phase 2 | |
Active, not recruiting |
NCT00101582 -
Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer
|
Phase 3 | |
Recruiting |
NCT06071637 -
Low Power Laser Therapy As Prevention Of Oral Mucositis And Oropharyngeal Pain In Patients Undergoing Allogenetic HSCT
|
Phase 3 |